Texas records just 17 abortions in four months in likely vast undercount
Board Chair-Elect Ghazaleh Moayedi discusses how we can’t trust vital statistics from oppressive governments.
Board Chair-Elect Ghazaleh Moayedi discusses how we can’t trust vital statistics from oppressive governments.
Our Fellow Dr. Mai Fleming discusses the potential for telemedicine to expand access to medication abortion.
Board Member Dr. Katie McHugh discusses how abortion bans create a chilling effect among doctors who are scared to misinterpret what constitutes a “medical emergency.”
Board Chair Dr. Kristyn Brandi shares how important it is to have mifepristone available via telemedicine in the post-Dobbs era.
Board Chair Dr. Kristyn Brandi discusses the many benefits of how Opill’s over-the-counter availability.
Our Fellow Chelsea Thibodeau shares how making Opill available over the counter is an “excellent and appropriate move…”
President & CEO Dr. Jamila Perritt talks about how abortion access cannot be meaningfully separated from comprehensive health care access.
Our Fellow Rachel Neal, an OB-GYN in Georgia, shares how the six-week ban in her state impacts women with non-viable pregnancies.